Back to Search
PETER HAMMERMAN, MD, PHD
MD, PHD
Medical Oncology Physician
NPI: 1518029545Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
234745(MA)
Research & Publications (9)
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival.
PMID 17942753·Blood·2008
7-preclinical
Fuel feeds function: energy metabolism and the T-cell response.
PMID 16239903·Nat Rev Immunol·2005
6-review
Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.
PMID 15705789·Blood·2005
7-preclinical
The Pim kinases control rapamycin-resistant T cell survival and activation.
PMID 15642745·J Exp Med·2005
7-preclinical
Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation.
PMID 15548703·Cancer Res·2004
7-preclinical
Beginnings of a signal-transduction pathway for bioenergetic control of cell survival.
PMID 15501677·Trends Biochem Sci·2004
6-review
Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand.
PMID 15180958·FASEB J·2004
7-preclinical
Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.
PMID 14517300·Mol Cell Biol·2003
7-preclinical
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.
PMID 12869584·Genes Dev·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 632-3000
Quick Facts
- NPI
- 1518029545
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile